New Square Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

New Square Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $16,618 - $20,264	24 Added 1200.0%	26 $21,000
Q2 2023 Aug 03, 2023	SELL	$700.03 - $830.35 $20,300 - $24,080	-29 Reduced 93.55%	2 $1,000
Q1 2023 May 01, 2023	BUY	$680.49 - $826.97 $19,734 - $23,982	29 Added 1450.0%	31 $25,000
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $1,411 - $1,532	2 New	2 $1,000
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $5,356 - $6,285	-9 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $4,304 - $5,471	9 New	9 $4,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.